Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. CeraSys, Incorporated
WARNING LETTER
•CeraSys, Incorporated•May 4, 2010

CeraSys, Incorporated – FDA Warning Letter, May 4, 2010

Record Details

An FDA inspection of CeraSys, Incorporated, conducted from April 28 to May 4, 2010, revealed significant violations concerning the manufacturing of CeraSys ZR zirconia dental blocks, classified as a medical device. The device was found to be adulterated under 21 U.S.C. 351(h) due to non-conformity with Current Good Manufacturing Practice (CGMP) requirements of the Quality System (QS) regulation (21 CFR Part 820). Key QS deficiencies included failures to establish and maintain procedures for design control (820.30(a)), corrective and preventive actions (820.100(a)), complaint handling (820.198(a)), process validation (820.75(a)), equipment calibration and maintenance (820.72(a)), purchasing controls and supplier evaluation (820.50(a)), device master records (820.181), and personnel training (820.25(b)). Furthermore, the device was misbranded under 21 U.S.C. 352(t)(2) for failing to comply with Medical Device Reporting (MDR) regulations (21 CFR Part 803), specifically lacking written MDR procedures (803.17). The device was also misbranded under 21 U.S.C. 352(o) due to an incomplete device listing, specifically for the porcelain powder used in manufacturing. The firm's response was received late and not reviewed. CeraSys must promptly correct these violations within fifteen working days, providing documentation and a timetable for future actions. Failure to comply could lead to regulatory actions such as seizure, injunctions, civil money penalties, and impact federal contracts, premarket approvals, and Certificates to Foreign Governments. The letter emphasizes the firm's responsibility to investigate and correct all underlying issues.

Company
CeraSys, Incorporated
Inspection date
May 4, 2010
Product type
Devices
Office
Los Angeles District Office
People
  • Alonza E. Cruse (Director)
  • Blake Bevill (Director)
  • William S. Vitale (Compliance Officer)
View Company Profile

ID · 54db6d5b-8849-43d8-ac4c-77f17959e2d5

Violation Codes10
21 U.S.C. 321(h)21 U.S.C. 351(h)21 CFR 820.30(a)21 CFR 820.100(a)21 CFR 820.198(a)21 CFR 820.75(a)21 CFR 820.72(a)21 CFR 820.50(a)21 CFR 820.18121 CFR 820.25(b)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore CeraSys, Incorporated
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.